Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Primary Liver Cancer 1

Interventions

pembrolizumab 308Nivolumab 159Carboplatin 158Cisplatin 140Cyclophosphamide 135Paclitaxel 128Magnetic Resonance Spectroscopy 98Specimen Handling 95Radiotherapy 92Gemcitabine 88Dexamethasone 86Biopsy 81Ipilimumab 81Docetaxel 78Doxorubicin 76Rituximab 70Etoposide 69durvalumab 61Lenalidomide 60Radiation 60Prednisone 59atezolizumab 59Taxes 58Pemetrexed 57Bevacizumab 54fludarabine 54olaparib 52Cytarabine 51Vincristine 51Fluorouracil 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × camrelizumab × 1 year × Clear all
NCT03083041 2026-03-03

A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Completed
210 enrolled 11 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03092895 2026-01-29

A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Completed
157 enrolled 17 charts
Gastrointestinal

Advanced Primary Liver Cancer

NCT04625803 2025-06-17

Neoadjuvant Therapy for Locally Advanced Colon Cancer

Zhejiang University

Phase 2 Completed
64 enrolled 11 charts
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡